Senegal-made sickle cell treatment raises hopes, reduces costs

A sickle cell treatment developed in Senegal is raising hopes among patients and healthcare stakeholders while potentially lowering treatment costs. The development highlights efforts to improve access to more affordable care for people living with sickle cell disease, though the headline does not provide details about the treatment or its availability.